Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis

AIMS: This study aimed to evaluate the efficacy and safety of bevacizumab eye drops compared with those of an intra-meibomian gland (MG) injection of bevacizumab when performed in conjunction with standard lid hygiene in patients with meibomian gland dysfunction (MGD)-associated posterior blephariti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantipat, Chitchanok, Kasetsuwan, Ngamjit, Chotikkakamthorn, Patraramon, Pongpirul, Krit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226372/
https://www.ncbi.nlm.nih.gov/pubmed/35755079
http://dx.doi.org/10.3389/fmed.2022.895418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226372/
https://www.ncbi.nlm.nih.gov/pubmed/35755079
http://dx.doi.org/10.3389/fmed.2022.895418

Ejemplares similares